^○Seock-Ah Im¹, Binghe Xu², Sung-Bae Kim³, Wei-Pang Chung⁴, Yeon Hee Park⁵, Min-Hwan Kim⁶, Ling-Ming Tseng⁷, Chi-Feng Chung⁸, Chiun-Sheng Huang⁹, Jee Hyun Kim¹⁰, Joanne Wing Yan Chiu¹¹, Toshinari Yamashita¹², Wei Li¹³, Caleb Lee¹⁴, Soichiro Nishijima¹⁵, Kyohei Hamada¹⁵, Yuji Nishiyama¹⁵, Masahiro Sugihara¹⁵, Javier Cortés^16,17,18, Hiroji Iwata¹⁹ (1.Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea, 2.Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China, 3.Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 4.Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 5.Samsung Medical Center, Seoul, Republic of Korea, 6.Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea, 7.Taipei Veterans General Hospital, Taipei, Taiwan, 8.Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, 9.National Taiwan University Hospital, Taipei, Taiwan, 10.Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea, 11.Queen Mary Hospital, Hong Kong, China, 12.Kanagawa Cancer Center, Kanagawa, Japan, 13.The First Hospital of Jilin University, Jilin, China, 14.Daiichi Sankyo, Inc., NJ, USA, 15.Daiichi Sankyo, Co., Ltd., Tokyo, Japan, 16.International Breast Cancer Center (IBCC), Quiron Group, Barcelona, Spain, 17.Scientific Department, Medica Scientia Innovation Research (MedSIR), Valencia, Spain, 18.Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, 19.Aichi Cancer Center Hospital, Aichi, Japan)

^○Toshimi Takano^1,2, Javier Cortes^3,4, David W. Cescon⁵, Seock-Ah Im⁶, Mastura Md Yusof⁷, Hiroji Iwata⁸, Norikazu Masuda⁹, Chiun-Sheng Huang¹⁰, Chi-Feng Chung¹¹, Koichiro Tsugawa¹², Yeon Hee Park¹³, Koji Matsumoto¹⁴, Kenichi Inoue¹⁵, Ava Kwong¹⁶, Sherene Loi¹⁷, Wei Fu¹⁸, Wilbur Pan¹⁸, Valia Karantza¹⁸, Hope S. Rugo¹⁹, Peter Schmid²⁰ (1.The Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Toranomon Hospital, Tokyo, Japan, 3.International Breast Cancer Center (IBCC), Quiron Group, Madrid and Barcelona, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain, 4.Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain, 5.Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada, 6.Seoul National University Hospital, Seoul, Republic of Korea, 7.Cancer Center at Pantai Hospital, Kuala Lumpur, Malaysia, 8.Aichi Cancer Center Hospital, Nagoya, Aichi, Japan, 9.Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan, 10.National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan, 11.Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, 12.St Marianna University School of Medicine Hospital, Kawasaki, Japan, 13.Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 14.Hyogo Cancer Center, Akashi, Hyogo, Japan, 15.Saitama Cancer Center, Saitama, Japan, 16.Queen Mary and Tung Wah Hospital and The University of Hong Kong-ShenZhen Hospital, China, 17.Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia, 18.Merck & Co., Inc., Kenilworth, NJ, USA, 19.University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA, 20.Barts Cancer Institute, Centre for Experimental Cancer Medicine, London, UK)

^○Masato Takahashi¹, Javier CortÉS², Rebecca Dent³, Lajos Pusztai⁴, Heather Mcarthur⁵, Sherko Kümmel⁶, Carsten Denkert⁷, Yeon Hee Park⁸, Seock-Ah Im⁹, Jin-Hee Ahn¹⁰, Hirofumi Mukai¹¹, Chiun-Sheng Huang¹², Shin-Cheh Chen¹³, Min Hwan Kim¹⁴, Liyi Jia¹⁵, Xin Tong Li¹⁵, Konstantinos Tryfonidis¹⁵, Vassiliki Karantza¹⁵, Hiroji Iwata¹⁶, Peter Schmid¹⁷ (1.Department of Breast Surgery, NHO Hokkaido Cancer Center, 2.Oncology Department, IOB Institute of Oncology, Quironsalud Group, Madrid & Barcelona and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, 3.National Cancer Center Singapore, Duke-NUS Medical School, Singapore, 4.Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA, 5.UT Southwestern Medical Center, Dallas, TX, USA, 6.Breast Unit, Kliniken Essen-Mitte Evang, Huyssens-Stiftung, Essen, Germany, 7.Institute of Pathology, Philipps University Marburg, Marburg, Germany, 8.Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 9.Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea, 10.Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 11.National Cancer Center Hospital East, Kashiwa-shi, Japan, 12.National Taiwan University Hospital, Taipei, Taiwan, 13.Chang Gung University Medical College, Taipei, Taiwan, 14.Yonsei University College of Medicine, Seoul, South Korea, 15.Merck & Co., Inc., Kenilworth, NJ, USA, 16.Aichi Cancer Center Hospital, Nagoya, Japan, 17.Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK)

^○Koji Matsumoto¹, Tadanori Nishikawa², Akihiro Hirakawa³, Mamiko Kawasaki⁴, Sawako Tomatsuri⁴, Yukari Nagasaka⁴, Nakamura Kenichi⁴, Hasegawa Kosei⁵, Masahiko Mori⁶, Yasuyuki Hirashima⁷, Kazuhiro Takehara⁸, Kazuya Ariyoshi⁹, Tomoyasu Kato¹⁰, Shigehiro Yagishita¹¹, Akinobu Hamada¹¹, Hiroshi Yoshida¹², Kan Yonemori² (1.Hyogo Cancer Center, 2.Department of Medical Oncology, National Cancer Center Hospital, 3.Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 4.Clinical Research Support Office, National Cancer Center Hospital, 5.Department of Gynecologic Oncology, Saitama Medical University International Medical Center, 6.Department of Gynecologic Oncology, Aichi Cancer Center Hospital, 7.Division of Gynecology, Shizuoka Cancer Center, 8.Department of Gynecologic Oncology, National Hospital Organization Shikoku Cancer Center, 9.Gynecology Service, National Hospital Organization Kyushu Cancer Center, 10.Department of Gynecologic Oncology, National Cancer Center Hospital, 11.Division of Molecular Pharmacology, National Cancer Center Research Institute, 12.Department of Diagnostic Pathology, National Cancer Center Hospital)